197 results on '"Paxton, Lynn A."'
Search Results
2. Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV in the United States : Recommendations from the U.S. Department of Health and Human Services
3. Factors associated with the uptake of and adherence to HIV pre-exposure prophylaxis in people who have injected drugs: an observational, open-label extension of the Bangkok Tenofovir Study
4. Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania
5. Renal Function of Participants in the Bangkok Tenofovir Study—Thailand, 2005–2012
6. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial
7. HIV Treatment Advances as Prevention
8. Factors Associated with Adherence and Concordance Between Measurement Strategies in an HIV Daily Oral Tenofovir/Emtricitibine as Pre-exposure Prophylaxis (Prep) Clinical Trial, Botswana, 2007–2010
9. The challenge of defining standards of prevention in HIV prevention trials
10. Estimated Community Seroprevalence of SARS-CoV-2 Antibodies — Two Georgia Counties, April 28–May 3, 2020
11. Postexposure Prophylaxis for HIV in Children and Adolescents After Sexual Assault: A Prospective Observational Study in an Urban Medical Center
12. Chemoprophylaxis with Tenofovir Disoproxil Fumarate Provided Partial Protection against Infection with Simian Human Immunodeficiency Virus in Macaques Given Multiple Virus Challenges
13. A Human Colorectal Explant Culture to Evaluate Topical Microbicides for the Prevention of HIV Infection
14. Oral pre-exposure prophylaxis for HIV prevention
15. High Mortality Among Non-HIV-Infected People Who Inject Drugs in Bangkok, Thailand, 2005-2012
16. The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugs
17. Malaria Surveillance — United States, 1992
18. Malaria Surveillance — United States, 1993
19. Planning for pre‐exposure prophylaxis to prevent HIV transmission: challenges and opportunities
20. Update and Overview of Practical Epidemiologic Aspects of HIV/AIDS among Injection Drug Users in the United States
21. HIV and AIDS in Women
22. List of Contributors
23. CD4+ cell count, viral load, and drug resistance patterns among heterosexual breakthrough HIV infections in a study of oral preexposure prophylaxis
24. Tenofovir-based HIV pre-exposure prophylaxis
25. Antiretroviral Preexposure Prophylaxis for HIV Prevention
26. Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana
27. Prevention of rectal SHIV transmission in macaques by intermittent pre-exposure prophylaxis (iPrEP) with oral Truvada: 003
28. Narrative Review: Antiretroviral Therapy to Prevent the Sexual Transmission of HIV-1
29. Population-based study of fertility in women with HIV-1 infection in Uganda
30. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis
31. Relative risks and population attributable fraction of incident HIV associated with symptoms of sexually transmitted diseases and treatable symptomatic sexually transmitted diseases in Rakai District, Uganda
32. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial
33. A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda
34. Ethics of HIV trials
35. Self-administered vaginal swabs for population-based assessment of Trichomonas vaginalis prevalence
36. Artemisinin combination therapy mass drug administration in a setting of low malaria endemicity: programmatic coverage and adherence during an observational study in Zanzibar
37. Levels of Intracellular Phosphorylated Tenofovir and Emtricitabine Correlate With Natural Substrate Concentrations in Peripheral Blood Mononuclear Cells of Persons Prescribed Daily Oral Truvada for HIV Pre-exposure Prophylaxis
38. Surveillance for sulfadoxine-pyrimethamine resistant malaria parasites in the Lake and Southern Zones, Tanzania, using pooling and next-generation sequencing
39. Evaluation of Sexual Risk Behavior Among Study Participants in the TDF2 PrEP Study Among Heterosexual Adults in Botswana
40. Brief Report
41. Chapter 33 - HIV and AIDS in Women
42. Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults
43. Assessment of Oral Fluid HIV Test Performance in an HIV Pre-Exposure Prophylaxis Trial in Bangkok, Thailand
44. HIV Treatment Advances as Prevention
45. Factors Associated with Adherence and Concordance Between Measurement Strategies in an HIV Daily Oral Tenofovir/Emtricitibine as Pre-exposure Prophylaxis (Prep) Clinical Trial, Botswana, 2007–2010
46. Normal Laboratory Reference Intervals among Healthy Adults Screened for a HIV Pre-Exposure Prophylaxis Clinical Trial in Botswana
47. Bone Mineral Density Changes among HIV-Uninfected Young Adults in a Randomised Trial of Pre-Exposure Prophylaxis with Tenofovir-Emtricitabine or Placebo in Botswana
48. Randomized Trial of Clinical Safety of Daily Oral Tenofovir Disoproxil Fumarate Among HIV-Uninfected Men Who Have Sex With Men in the United States
49. Sexual Risk Behavior Among HIV-Uninfected Men Who Have Sex With Men Participating in a Tenofovir Preexposure Prophylaxis Randomized Trial in the United States
50. HIV-1 Evolution in Breakthrough Infections in a Human Trial of Oral Pre-exposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.